Examples of using Lymphomas in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
relief because he was riddled with fatty lymphomas and joy that you can now get a new kitty.
has been created specifically for follicular lymphoma and other indolent lymphomas.
The treatment of leukaemias and lymphomas consists of intensive chemotherapy in accordance with the standards of the GPOH.
T-cell and aggressive(diffuse) lymphomas.
T-lymphocytes- white blood cells- causes the appearance of lymphoma, which in turn is divided into Hodgkin's lymphomas and non-Hodgkin's lymphomas, differing morphology of the disease.
R development of lymphomas or other malignancies in patients treated with a TNF-antagonist cannot be.
The types of non-Hodgkin's lymphoma can be described as B-cell lymphomas or T-cell lymphomas,
the observed rate of lymphomas is approximately 1.2 per 1000 patient years.
increases in the incidence of malignant lymphomas and mammary gland tumours(in females) occurred.
leukaemia and lymphomas.
MabionCD20 is built on monoclonal antibodies used in the treatment of blood cancers, lymphomas and leukemias, as well as in the treatment of rheumatoid arthritis.
Treatment was according to the guidelines of the Polish Paediatric Group for Treatment of Leukaemia and Lymphomas and the Polish Paediatric Group for Treatment of Solid Tumours.
This year, the Company presented the latest results of research on the development of potential drugs for treatment of leukemias and lymphomas.
and 6 with hematologic malignancies 4 with lymphomas and 2 with myelodysplastic syndromes.
Patients HIV status, HTLV-1 for T-cell lymphomas and EVB status for B-cell lymphomas.
Additionally, H. pylori has been associated with lymphomas and adenocarcinomas of the stomach,
Apart from the above listed conditions, it is also used to treat non-Hodgkin's lymphomas, breast cancer,
The rate(95% confidence interval) of lymphomas was 0.7(0.2,
The rate(95% confidence interval) of lymphomas was 1.0(0.2,
Post-marketing spontaneous serious adverse events with infliximab in the paediatric population have included malignancies including hepatosplenic T-cell lymphomas, transient hepatic enzyme abnormalities,